Donor dopamine pretreatment and graft function after kidney transplantation

JAMA

Volumn 303, Issue 3, 2010, Pages 230-

  Silverstein, Jeffrey H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT;

DRUG APPROVAL; GRAFT DYSFUNCTION; GRAFT SURVIVAL; INFORMED CONSENT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LETTER; MEDICAL RESEARCH; OBSERVATIONAL STUDY; ORGAN PRESERVATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RENAL PROTECTION; SAFETY; ETHICS; HUMAN; NOTE; RANDOMIZED CONTROLLED TRIAL; TRANSPLANTATION;

DOPAMINE; DOPAMINE AGENTS; HUMANS; INFORMED CONSENT; KIDNEY TRANSPLANTATION; ORGAN PRESERVATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TISSUE AND ORGAN PROCUREMENT;

EID: 74549174793     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1994     Document Type: Letter

References (1)

1. Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA. 2009;302(10):1067-1075.